CNS(CNS)
CNS
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E | FY2028E |
|---|---|---|---|
| Revenue Avg | $617M | $690M | $606M |
| Low | $610M | $682M | $598M |
| High | $625M | $698M | $613M |
| EBITDA Avg | $243M | $272M | $239M |
| Low | $240M | $268M | $236M |
| High | $246M | $275M | $241M |
| EBIT Avg | $232M | $259M | $228M |
| Low | $229M | $256M | $225M |
| High | $235M | $263M | $230M |
| Net Income Avg | $178M | $201M | $187M |
| Low | $175M | $199M | $185M |
| High | $182M | $202M | $190M |
| EPS Avg | $3.45 | $3.89 | $3.63 |
| Low | $3.38 | $3.85 | $3.57 |
| High | $3.52 | $3.92 | $3.69 |
| Analysts (Rev / EPS) | 1 / 2 | 1 / 2 | 1 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $158M | $163M | $163M | $169M | $162M | $165M |
| Low | $158M | $163M | $163M | $169M | $162M | $165M |
| High | $158M | $163M | $163M | $169M | $162M | $165M |
| EBITDA Avg | $62M | $64M | $64M | $67M | $64M | $65M |
| Low | $62M | $64M | $64M | $67M | $64M | $65M |
| High | $62M | $64M | $64M | $67M | $64M | $65M |
| EBIT Avg | $59M | $61M | $61M | $64M | $61M | $62M |
| Low | $59M | $61M | $61M | $64M | $61M | $62M |
| High | $59M | $61M | $61M | $64M | $61M | $62M |
| Net Income Avg | $47M | $47M | $48M | $49M | $53M | $53M |
| Low | $47M | $47M | $48M | $49M | $53M | $53M |
| High | $47M | $48M | $48M | $49M | $53M | $53M |
| EPS Avg | $0.91 | $0.92 | $0.93 | $0.94 | $1.02 | $1.03 |
| Low | $0.91 | $0.90 | $0.93 | $0.94 | $1.02 | $1.03 |
| High | $0.91 | $0.93 | $0.93 | $0.94 | $1.02 | $1.03 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 2 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |